In WHO°II meningiomas reduced expression of LEPR and MN1 resulted in a significantly shorter PFS, while in WHO°III meningiomas this was the case for a higher expression levels of PTTG1 and UBE2C (Figure 5). The gene discussed is MN1; the disease is meningioma.